These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8660164)

  • 1. Use of the ganciclovir implant in the treatment of recurrent cytomegalovirus retinitis.
    Marx JL; Kapusta MA; Patel SS; LaBree LD; Walonker F; Rao NA; Chong LP
    Arch Ophthalmol; 1996 Jul; 114(7):815-20. PubMed ID: 8660164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of recurrent cytomegalovirus retinitis with the ganciclovir implant.
    Roth DB; Feuer WJ; Blenke AJ; Davis JL
    Am J Ophthalmol; 1999 Mar; 127(3):276-82. PubMed ID: 10088736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of relapsed cytomegalovirus retinitis with the sustained-release ganciclovir implant.
    Hatton MP; Duker JS; Reichel E; Morley MG; Puliafito CA
    Retina; 1998; 18(1):50-5. PubMed ID: 9502281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of bilateral cytomegalovirus retinitis with sustained-release ganciclovir implants in a child.
    Malley DS; Barone R; Heinemann MH
    Am J Ophthalmol; 1996 Nov; 122(5):731-2. PubMed ID: 8909217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications after implantation of intraocular devices in patients with cytomegalovirus retinitis.
    Guembel HO; Krieglsteiner S; Rosenkranz C; Hattenbach LO; Koch FH; Ohrloff C
    Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):824-9. PubMed ID: 10502057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis.
    Lim JI; Wolitz RA; Dowling AH; Bloom HR; Irvine AR; Schwartz DM
    Am J Ophthalmol; 1999 Mar; 127(3):288-93. PubMed ID: 10088738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A foveal-sparing pattern of cytomegalovirus retinitis in the acquired immunodeficiency syndrome.
    Luckie AP; Ai E
    Aust N Z J Ophthalmol; 1996 Feb; 24(1):53-9. PubMed ID: 8743006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of potent antiretroviral therapy on recurrent cytomegalovirus retinitis treated with the ganciclovir implant.
    Davis JL; Tabandeh H; Feuer WJ; Kumbhat S; Roth DB; Chaudhry NA
    Am J Ophthalmol; 1999 Mar; 127(3):283-7. PubMed ID: 10088737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.
    Martin DF; Parks DJ; Mellow SD; Ferris FL; Walton RC; Remaley NA; Chew EY; Ashton P; Davis MD; Nussenblatt RB
    Arch Ophthalmol; 1994 Dec; 112(12):1531-9. PubMed ID: 7993207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
    Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
    Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pars plana implantation of a ganciclovir drug carrier in patients with cytomegalovirus retinitis and AIDS. Indications, follow-up and postoperative complications].
    Gümbel H; Rosenkranz C; Schnaudigel OE; Mauck K; Fries U; Ohrloff C
    Ophthalmologe; 1997 Oct; 94(10):713-8. PubMed ID: 9432239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant.
    Muccioli C; Belfort R
    Braz J Med Biol Res; 2000 Jul; 33(7):779-89. PubMed ID: 10881053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus optic neuritis: characteristics, therapy and survival.
    Mansor AM; Li HK
    Ophthalmologica; 1995; 209(5):260-6. PubMed ID: 8570149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes in patients with cytomegalovirus retinitis treated with ganciclovir implant.
    Oktavec KC; Nolan K; Brown DM; Dunn JP; Livingston AG; Thorne JE
    Am J Ophthalmol; 2012 Apr; 153(4):728-33, 733.e1-2. PubMed ID: 22265144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganciclovir implants: one year later.
    Cadman J
    GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of cytomegalovirus retinitis following the use of ganciclovir implants.
    McCluskey PJ; Shah R; Versace P
    Aust N Z J Ophthalmol; 1998 Aug; 26(3):207-10. PubMed ID: 9717750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serous retinal detachments in a patient with clinically resistant cytomegalovirus retinitis.
    Dodds EM; Lowder CY; Foster RE; Avery RK; Prayson RA
    Arch Ophthalmol; 1996 Jul; 114(7):896-7. PubMed ID: 8660181
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravitreal sustained-release ganciclovir implantation to control cytomegalovirus retinitis in AIDS.
    Dhillon B; Kamal A; Leen C
    Int J STD AIDS; 1998 Apr; 9(4):227-30. PubMed ID: 9598751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome.
    Kempen JH; Jabs DA; Dunn JP; West SK; Tonascia J
    Arch Ophthalmol; 2001 Jan; 119(1):33-40. PubMed ID: 11146724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.